Gladigen Overview

  • Founded
  • 2015

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

Gladigen General Information


Operator of a biotechnology company specializing in peripheral nerve repair. The company designs, develops and commercializes technology that aligns and seals nerves severed by disease, traumatic events or surgical procedures, overcoming complications from the misdirection and loss of axons.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4586 South West 48th Way
  • Suite 106
  • Gainesville, FL 32608
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gladigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Gladigen’s complete valuation and funding history, request access »

Gladigen Executive Team (1)

Name Title Board Seat Contact Info
Christopher Gladin Ph.D Chief Executive Officer
To view Gladigen’s complete executive team members history, request access »